Literature DB >> 9023276

Morphine tolerance and dependence in the rat intestine in vivo.

C L Williams1, C C Bihm, G C Rosenfeld, T F Burks.   

Abstract

There has been no previous demonstration of opioid tolerance and dependence with respect to the propulsive and contractile activities of the gut in vivo. In the experiments described herein, morphine was administered continuously (1 mg/kg/hr s.c., 72 hr) and/or by bolus injection (2 mg/kg) and intestinal motility and transit were evaluated in unanesthetized rats. Tolerance in intestinal motility (contractions) and propulsion (transit) was measured in two ways, i.e., by measuring the time required for motility and propulsion to return to control values and by measuring the loss of effectiveness of bolus morphine administered to animals receiving continuous infusion of the opiate. The dose of morphine chosen for continuous administration (1 mg/kg/hr s.c. via Alzet minipumps) was based on the dose at which morphine inhibited intestinal propulsion by 50%. Morphine (1 mg/kg/hr) decreased the frequency of contractions in, and propulsion along, the small bowel and colon and produced mild antinociception. The frequency of duodenal and colonic contractions returned to normal within 13 to 16 hr. After 24 hr of morphine treatment, the inhibitory effects of bolus doses of morphine on motility and transit were diminished; the effects were eventually lost (48 hr). Similarly, the antinociceptive effects of bolus doses of morphine were diminished by 18 hr and lost by 24 hr. Naloxone (0.1 mg/kg s.c.) given to morphine-tolerant animals (72 hr) resulted in an increase in the frequency and amplitude of contractions in the colon, an increase in the propulsive activity of the small intestine and colon and diarrhea. These results provide direct demonstration of opioid tolerance and dependence of contractile and propulsive activity in the rat intestine in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9023276

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  Site and mechanism of morphine tolerance in the gastrointestinal tract.

Authors:  H I Akbarali; A Inkisar; W L Dewey
Journal:  Neurogastroenterol Motil       Date:  2014-10       Impact factor: 3.598

2.  Morphological changes of cell proliferation and apoptosis in rat jejunal mucosa at different ages.

Authors:  Li Wang; Jian Li; Qing Li; Jian Zhang; Xiang-Lin Duan
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

3.  Morphine tolerance in the mouse ileum and colon.

Authors:  Gracious R Ross; Bichoy H Gabra; William L Dewey; Hamid I Akbarali
Journal:  J Pharmacol Exp Ther       Date:  2008-08-05       Impact factor: 4.030

4.  Interaction of hemorrhagic shock and subsequent polymicrobial sepsis on gastrointestinal motility.

Authors:  Marcus Overhaus; Sandra Toegel; Anthony J Bauer
Journal:  Shock       Date:  2009-04       Impact factor: 3.454

5.  Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal.

Authors:  Bernadett Pintér-Kübler; Szilamér Ferenczi; Cristina Núnez; Edina Zelei; Agnes Polyák; M Victoria Milanés; Krisztina J Kovács
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

Review 6.  Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders.

Authors:  Md Jakaria; Duk-Yeon Cho; Md Ezazul Haque; Govindarajan Karthivashan; In-Su Kim; Palanivel Ganesan; Dong-Kug Choi
Journal:  Oxid Med Cell Longev       Date:  2018-03-20       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.